Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Steroid versus intra-articular ozone for chronic knee osteoarthritis
IRCT20100827004641N18Phase 3Completed
- Sponsor
- Physical Medicine and Rehabilitation Research Center
- Start
- Nov 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-blind trial of triamcinolone, medical ozonated water and lidocaine in knee osteoarthritis (OA) (2 arms), sponsored by Physical Medicine and Rehabilitation Research Center. Primary endpoint: Pain reduction after injection. Started Nov 2019; status: completed.
02
Drugs
triamcinolonemedical ozonated waterlidocaine
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on IRCT20100827004641N18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20100827004641N18.